|
|
Vaccine Detail
|
cAd3-EBO S |
| Vaccine Information |
- Vaccine Name: cAd3-EBO S
- Target Pathogen: Ebola virus
- Target Disease: Ebola hemorrhagic fever
- Product Name: Ebola Sudan Chimpanzee Adenovirus Vector Vaccine
- Type: Recombinant vector vaccine
- Status: Licensed
- Location Licensed: Kampala, Uganda
- Host Species for Licensed Use: Human
- GP from Sudan ebolavirus
gene engineering:
- Type: Recombinant vector construction
- Description: The recombinant chimpanzee adenovirus Type 3-vectored Ebola vaccine, VRC-EBOADC086-00-VP (cAd3-EBO S), is composed of a cAd3 vector that encodes Ebola Sudan wild type glycoprotein (WT GP).(Ledgerwood et al., 2017)
- Detailed Gene Information: Click Here.
- GP from Zaire ebolavirus
gene engineering:
- Type: Recombinant vector construction
- Description: cAd3-EBO glycoprotein Zaire and cAd3-EBO glycoprotein Sudan were made and mixed in a 1:1 ratio (Ledgerwood et al., 2017)
- Detailed Gene Information: Click Here.
- Immunization Route: Intramuscular injection (i.m.)
|
| Host Response |
|
|
| References |
|
|
|
